DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
South Korea flag South Korea · Delayed Price · Currency is KRW
15,050
-70 (-0.46%)
Apr 2, 2025, 3:30 PM KST

DongKook Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
61,21947,17552,89650,34555,925
Upgrade
Depreciation & Amortization
28,46221,09819,18717,35815,112
Upgrade
Loss (Gain) From Sale of Assets
-2,154-752.89-609.49-1,0422.32
Upgrade
Loss (Gain) From Sale of Investments
-3,2845,8145,434-1,376-1,881
Upgrade
Loss (Gain) on Equity Investments
-2,551896.71-1,122-1,031-451.62
Upgrade
Stock-Based Compensation
-39.2-162.46-297.32-24.01673.63
Upgrade
Provision & Write-off of Bad Debts
-165.02663.85223.25-713.061,752
Upgrade
Other Operating Activities
19,1862,2215,0343,41316,544
Upgrade
Change in Accounts Receivable
-13,751-27,785-10,6643,656-18,312
Upgrade
Change in Inventory
-17,310-19,223-18,019-24,747-17,298
Upgrade
Change in Accounts Payable
12,56128,9544,606-1,3497,845
Upgrade
Change in Unearned Revenue
415.170.1---
Upgrade
Change in Other Net Operating Assets
-6,498-17,107-15,759163.08-802.99
Upgrade
Operating Cash Flow
76,09141,79340,90944,65459,108
Upgrade
Operating Cash Flow Growth
82.07%2.16%-8.39%-24.45%-14.93%
Upgrade
Capital Expenditures
-27,291-34,177-47,914-51,006-39,607
Upgrade
Sale of Property, Plant & Equipment
2,9983,57925.3518.2729.4
Upgrade
Cash Acquisitions
-31,703---13,000-
Upgrade
Divestitures
2,5722.03---
Upgrade
Sale (Purchase) of Intangibles
-3,937-5,413-4,0581,330-1,688
Upgrade
Investment in Securities
-5,631-21,13131,83716,655-49,353
Upgrade
Other Investing Activities
4,7474,7578,5072,2202,609
Upgrade
Investing Cash Flow
-64,864-52,391-12,408-43,530-96,940
Upgrade
Short-Term Debt Issued
39,57132,35812,67030,6878,951
Upgrade
Long-Term Debt Issued
22,900-35,00022,5007,300
Upgrade
Total Debt Issued
62,47132,35847,67053,18716,251
Upgrade
Short-Term Debt Repaid
-45,999-21,084-57,836-10,854-9,981
Upgrade
Long-Term Debt Repaid
-27,618-3,049-22,248-3,114-2,818
Upgrade
Total Debt Repaid
-73,616-24,133-80,084-13,968-12,799
Upgrade
Net Debt Issued (Repaid)
-11,1468,225-32,41439,2193,452
Upgrade
Dividends Paid
-8,313-8,051-8,049-8,049-7,155
Upgrade
Other Financing Activities
-2,846-2,472672.13-1,437-1,809
Upgrade
Financing Cash Flow
-22,305-2,298-39,79229,73322,959
Upgrade
Foreign Exchange Rate Adjustments
797.75-245.54-459.6150.51-849.82
Upgrade
Miscellaneous Cash Flow Adjustments
-0----
Upgrade
Net Cash Flow
-10,281-13,141-11,75030,907-15,723
Upgrade
Free Cash Flow
48,8007,616-7,005-6,35219,502
Upgrade
Free Cash Flow Growth
540.73%----56.03%
Upgrade
Free Cash Flow Margin
6.01%1.04%-1.06%-1.07%3.49%
Upgrade
Free Cash Flow Per Share
1090.81170.27-156.64-142.04436.09
Upgrade
Cash Interest Paid
3,3962,921898.192,6992,133
Upgrade
Cash Income Tax Paid
11,33116,61411,67819,97518,218
Upgrade
Levered Free Cash Flow
24,190-15,328-19,169-14,97722,478
Upgrade
Unlevered Free Cash Flow
27,001-11,661-16,469-13,17523,601
Upgrade
Change in Net Working Capital
20,10934,80129,34920,3452,517
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.